-
1
-
-
33749871965
-
The experimental study of tumor progression: a review
-
Foulds L. The experimental study of tumor progression: a review. Cancer Res. 1954, 14:327-339.
-
(1954)
Cancer Res.
, vol.14
, pp. 327-339
-
-
Foulds, L.1
-
2
-
-
80155191242
-
Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
-
Torti D., Trusolino L. Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils. EMBO Mol. Med. 2011, 3:623-636.
-
(2011)
EMBO Mol. Med.
, vol.3
, pp. 623-636
-
-
Torti, D.1
Trusolino, L.2
-
4
-
-
28844481452
-
The KRAS oncogene: past, present, and future
-
Kranenburg O. The KRAS oncogene: past, present, and future. Biochim. Biophys. Acta 2005, 1756:81-82.
-
(2005)
Biochim. Biophys. Acta
, vol.1756
, pp. 81-82
-
-
Kranenburg, O.1
-
6
-
-
33947594129
-
Hyperactive Ras in developmental disorders and cancer
-
Schubbert S., Shannon K., Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 2007, 7:295-308.
-
(2007)
Nat. Rev. Cancer
, vol.7
, pp. 295-308
-
-
Schubbert, S.1
Shannon, K.2
Bollag, G.3
-
7
-
-
0029002907
-
Aberrant function of the Ras signal transduction pathway in human breast cancer
-
Clark G.J., Der C.J. Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res. Treat. 1995, 35:133-144.
-
(1995)
Breast Cancer Res. Treat.
, vol.35
, pp. 133-144
-
-
Clark, G.J.1
Der, C.J.2
-
8
-
-
79959210731
-
Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families
-
Hollestelle A., Pelletier C., Hooning M., Crepin E., Schutte M., Look M., Collee J.M., Nieuwlaat A., Dorssers L.C., Seynaeve C., Aulchenko Y.S., Martens J.W., van den Ouweland A.M., Weidhaas J.B. Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families. Breast Cancer Res. Treat. 2011, 128:79-84.
-
(2011)
Breast Cancer Res. Treat.
, vol.128
, pp. 79-84
-
-
Hollestelle, A.1
Pelletier, C.2
Hooning, M.3
Crepin, E.4
Schutte, M.5
Look, M.6
Collee, J.M.7
Nieuwlaat, A.8
Dorssers, L.C.9
Seynaeve, C.10
Aulchenko, Y.S.11
Martens, J.W.12
van den Ouweland, A.M.13
Weidhaas, J.B.14
-
9
-
-
3042742432
-
Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis
-
Eckert L.B., Repasky G.A., Ulku A.S., McFall A., Zhou H., Sartor C.I., Der C.J. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Res. 2004, 64:4585-4592.
-
(2004)
Cancer Res.
, vol.64
, pp. 4585-4592
-
-
Eckert, L.B.1
Repasky, G.A.2
Ulku, A.S.3
McFall, A.4
Zhou, H.5
Sartor, C.I.6
Der, C.J.7
-
10
-
-
84861463747
-
The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer
-
Pilarski R., Patel D.A., Weitzel J., McVeigh T., Dorairaj J.J., Heneghan H.M., Miller N., Weidhaas J.B., Kerin M.J., McKenna M., Wu X., Hildebrandt M., Zelterman D., Sand S., Shulman L.P. The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer. PLoS ONE 2012, 7:e37891.
-
(2012)
PLoS ONE
, vol.7
-
-
Pilarski, R.1
Patel, D.A.2
Weitzel, J.3
McVeigh, T.4
Dorairaj, J.J.5
Heneghan, H.M.6
Miller, N.7
Weidhaas, J.B.8
Kerin, M.J.9
McKenna, M.10
Wu, X.11
Hildebrandt, M.12
Zelterman, D.13
Sand, S.14
Shulman, L.P.15
-
11
-
-
0035137292
-
Marine natural products
-
Faulkner D.J. Marine natural products. Nat. Prod. Rep. 2001, 18:1-49.
-
(2001)
Nat. Prod. Rep.
, vol.18
, pp. 1-49
-
-
Faulkner, D.J.1
-
12
-
-
0028163714
-
Strategies for the discovery of secondary metabolites from marine bacteria: ecological perspectives
-
Jensen P.R., Fenical W. Strategies for the discovery of secondary metabolites from marine bacteria: ecological perspectives. Annu. Rev. Microbiol. 1994, 48:559-584.
-
(1994)
Annu. Rev. Microbiol.
, vol.48
, pp. 559-584
-
-
Jensen, P.R.1
Fenical, W.2
-
13
-
-
21244491657
-
2-Pyrone natural products and mimetics: isolation, characterisation and biological activity
-
McGlacken G.P., Fairlamb I.J. 2-Pyrone natural products and mimetics: isolation, characterisation and biological activity. Nat. Prod. Rep. 2005, 22:369-385.
-
(2005)
Nat. Prod. Rep.
, vol.22
, pp. 369-385
-
-
McGlacken, G.P.1
Fairlamb, I.J.2
-
14
-
-
0027345554
-
Microbial pyran-2-ones and dihydropyran-2-ones
-
Dickinson J.M. Microbial pyran-2-ones and dihydropyran-2-ones. Nat. Prod. Rep. 1993, 10:71-98.
-
(1993)
Nat. Prod. Rep.
, vol.10
, pp. 71-98
-
-
Dickinson, J.M.1
-
15
-
-
0030895692
-
Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor
-
Poppe S.M., Slade D.E., Chong K.T., Hinshaw R.R., Pagano P.J., Markowitz M., Ho D.D., Mo H., Gorman R.R., Dueweke T.J., Thaisrivongs S., Tarpley W.G. Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor. Antimicrob. Agents Chemother. 1997, 41:1058-1063.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1058-1063
-
-
Poppe, S.M.1
Slade, D.E.2
Chong, K.T.3
Hinshaw, R.R.4
Pagano, P.J.5
Markowitz, M.6
Ho, D.D.7
Mo, H.8
Gorman, R.R.9
Dueweke, T.J.10
Thaisrivongs, S.11
Tarpley, W.G.12
-
16
-
-
10544246488
-
Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors
-
Thaisrivongs S., Romero D.L., Tommasi R.A., Janakiraman M.N., Strohbach J.W., Turner S.R., Biles C., Morge R.R., Johnson P.D., Aristoff P.A., Tomich P.K., Lynn J.C., Horng M.M., Chong K.T., Hinshaw R.R., Howe W.J., Finzel B.C., Watenpaugh K.D. Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors. J. Med. Chem. 1996, 39:4630-4642.
-
(1996)
J. Med. Chem.
, vol.39
, pp. 4630-4642
-
-
Thaisrivongs, S.1
Romero, D.L.2
Tommasi, R.A.3
Janakiraman, M.N.4
Strohbach, J.W.5
Turner, S.R.6
Biles, C.7
Morge, R.R.8
Johnson, P.D.9
Aristoff, P.A.10
Tomich, P.K.11
Lynn, J.C.12
Horng, M.M.13
Chong, K.T.14
Hinshaw, R.R.15
Howe, W.J.16
Finzel, B.C.17
Watenpaugh, K.D.18
-
17
-
-
12944322516
-
Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class
-
Turner S.R., Strohbach J.W., Tommasi R.A., Aristoff P.A., Johnson P.D., Skulnick H.I., Dolak L.A., Seest E.P., Tomich P.K., Bohanon M.J., Horng M.M., Lynn J.C., Chong K.T., Hinshaw R.R., Watenpaugh K.D., Janakiraman M.N., Thaisrivongs S. Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class. J. Med. Chem. 1998, 41:3467-3476.
-
(1998)
J. Med. Chem.
, vol.41
, pp. 3467-3476
-
-
Turner, S.R.1
Strohbach, J.W.2
Tommasi, R.A.3
Aristoff, P.A.4
Johnson, P.D.5
Skulnick, H.I.6
Dolak, L.A.7
Seest, E.P.8
Tomich, P.K.9
Bohanon, M.J.10
Horng, M.M.11
Lynn, J.C.12
Chong, K.T.13
Hinshaw, R.R.14
Watenpaugh, K.D.15
Janakiraman, M.N.16
Thaisrivongs, S.17
-
18
-
-
51749088156
-
Redox regulation of cell survival
-
Trachootham D., Lu W., Ogasawara M.A., Nilsa R.D., Huang P. Redox regulation of cell survival. Antioxid. Redox Signal. 2008, 10:1343-1374.
-
(2008)
Antioxid. Redox Signal.
, vol.10
, pp. 1343-1374
-
-
Trachootham, D.1
Lu, W.2
Ogasawara, M.A.3
Nilsa, R.D.4
Huang, P.5
-
19
-
-
84865236519
-
A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells
-
Kim R.K., Kim M.J., Yoon C.H., Lim E.J., Yoo K.C., Lee G.H., Kim Y.H., Kim H., Jin Y.B., Lee Y.J., Cho C.G., Oh Y.S., Gye M.C., Suh Y., Lee S.J. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells. Mol. Pharmacol. 2012, 82:400-407.
-
(2012)
Mol. Pharmacol.
, vol.82
, pp. 400-407
-
-
Kim, R.K.1
Kim, M.J.2
Yoon, C.H.3
Lim, E.J.4
Yoo, K.C.5
Lee, G.H.6
Kim, Y.H.7
Kim, H.8
Jin, Y.B.9
Lee, Y.J.10
Cho, C.G.11
Oh, Y.S.12
Gye, M.C.13
Suh, Y.14
Lee, S.J.15
-
20
-
-
82555164996
-
A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, synergistically enhances radiation sensitivity in human cervical cancer cells
-
Woo S.J., Kim M.J., Kim R.K., Yoon C.H., Lim E.J., An S., Suh Y., Song J.Y., Kim I.G., Cho C.G., Lee S.J. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, synergistically enhances radiation sensitivity in human cervical cancer cells. Anticancer Drugs 2012, 23:43-50.
-
(2012)
Anticancer Drugs
, vol.23
, pp. 43-50
-
-
Woo, S.J.1
Kim, M.J.2
Kim, R.K.3
Yoon, C.H.4
Lim, E.J.5
An, S.6
Suh, Y.7
Song, J.Y.8
Kim, I.G.9
Cho, C.G.10
Lee, S.J.11
-
21
-
-
79958004725
-
Eckol suppresses maintenance of stemness and malignancies in glioma stem-like cells
-
Hyun K.H., Yoon C.H., Kim R.K., Lim E.J., An S., Park M.J., Hyun J.W., Suh Y., Kim M.J., Lee S.J. Eckol suppresses maintenance of stemness and malignancies in glioma stem-like cells. Toxicol. Appl. Pharmacol. 2011.
-
(2011)
Toxicol. Appl. Pharmacol.
-
-
Hyun, K.H.1
Yoon, C.H.2
Kim, R.K.3
Lim, E.J.4
An, S.5
Park, M.J.6
Hyun, J.W.7
Suh, Y.8
Kim, M.J.9
Lee, S.J.10
-
22
-
-
0023651180
-
The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231
-
Kozma S.C., Bogaard M.E., Buser K., Saurer S.M., Bos J.L., Groner B., Hynes N.E. The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231. Nucleic Acids Res. 1987, 15:5963-5971.
-
(1987)
Nucleic Acids Res.
, vol.15
, pp. 5963-5971
-
-
Kozma, S.C.1
Bogaard, M.E.2
Buser, K.3
Saurer, S.M.4
Bos, J.L.5
Groner, B.6
Hynes, N.E.7
-
23
-
-
77953484480
-
Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition
-
Mendez M.G., Kojima S., Goldman R.D. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J.: Off. Pub. Fed. Am. Soc. Exp. Biol. 2010, 24:1838-1851.
-
(2010)
FASEB J.: Off. Pub. Fed. Am. Soc. Exp. Biol.
, vol.24
, pp. 1838-1851
-
-
Mendez, M.G.1
Kojima, S.2
Goldman, R.D.3
-
24
-
-
77958066728
-
Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines
-
Keller P.J., Lin A.F., Arendt L.M., Klebba I., Jones A.D., Rudnick J.A., DiMeo T.A., Gilmore H., Jefferson D.M., Graham R.A., Naber S.P., Schnitt S., Kuperwasser C. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Res. 2010, 12:R87.
-
(2010)
Breast Cancer Res.
, vol.12
-
-
Keller, P.J.1
Lin, A.F.2
Arendt, L.M.3
Klebba, I.4
Jones, A.D.5
Rudnick, J.A.6
DiMeo, T.A.7
Gilmore, H.8
Jefferson, D.M.9
Graham, R.A.10
Naber, S.P.11
Schnitt, S.12
Kuperwasser, C.13
-
25
-
-
51349169062
-
K-ras/PI3K-Akt signaling is essential for zebrafish hematopoiesis and angiogenesis
-
Liu L., Zhu S., Gong Z., Low B.C. K-ras/PI3K-Akt signaling is essential for zebrafish hematopoiesis and angiogenesis. PLoS ONE 2008, 3:e2850.
-
(2008)
PLoS ONE
, vol.3
-
-
Liu, L.1
Zhu, S.2
Gong, Z.3
Low, B.C.4
-
26
-
-
0036797096
-
Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years
-
Devereux T.R., Holliday W., Anna C., Ress N., Roycroft J., Sills R.C. Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years. Carcinogenesis 2002, 23:1737-1743.
-
(2002)
Carcinogenesis
, vol.23
, pp. 1737-1743
-
-
Devereux, T.R.1
Holliday, W.2
Anna, C.3
Ress, N.4
Roycroft, J.5
Sills, R.C.6
-
27
-
-
70349479251
-
Oncogenic Ras signals through activation of both phosphoinositide 3-kinase and Rac1 to induce c-Jun NH2-terminal kinase-mediated, caspase-independent cell death
-
Byun J.Y., Kim M.J., Yoon C.H., Cha H., Yoon G., Lee S.J. Oncogenic Ras signals through activation of both phosphoinositide 3-kinase and Rac1 to induce c-Jun NH2-terminal kinase-mediated, caspase-independent cell death. Mol. Cancer Res. 2009, 7:1534-1542.
-
(2009)
Mol. Cancer Res.
, vol.7
, pp. 1534-1542
-
-
Byun, J.Y.1
Kim, M.J.2
Yoon, C.H.3
Cha, H.4
Yoon, G.5
Lee, S.J.6
-
28
-
-
65649108558
-
A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival
-
Singh A., Greninger P., Rhodes D., Koopman L., Violette S., Bardeesy N., Settleman J. A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell 2009, 15:489-500.
-
(2009)
Cancer Cell
, vol.15
, pp. 489-500
-
-
Singh, A.1
Greninger, P.2
Rhodes, D.3
Koopman, L.4
Violette, S.5
Bardeesy, N.6
Settleman, J.7
-
29
-
-
79960052850
-
Ras in cancer and developmental diseases
-
Fernandez-Medarde A., Santos E. Ras in cancer and developmental diseases. Genes Cancer 2011, 2:344-358.
-
(2011)
Genes Cancer
, vol.2
, pp. 344-358
-
-
Fernandez-Medarde, A.1
Santos, E.2
-
30
-
-
77954554630
-
Clinical relevance of KRAS in human cancers
-
Jancik S., Drabek J., Radzioch D., Hajduch M. Clinical relevance of KRAS in human cancers. J. Biomed. Biotechnol. 2010, 2010:150960.
-
(2010)
J. Biomed. Biotechnol.
, vol.2010
, pp. 150960
-
-
Jancik, S.1
Drabek, J.2
Radzioch, D.3
Hajduch, M.4
-
31
-
-
0033981639
-
A genome-wide survey of RAS transformation targets
-
Zuber J., Tchernitsa O.I., Hinzmann B., Schmitz A.C., Grips M., Hellriegel M., Sers C., Rosenthal A., Schafer R. A genome-wide survey of RAS transformation targets. Nat. Genet. 2000, 24:144-152.
-
(2000)
Nat. Genet.
, vol.24
, pp. 144-152
-
-
Zuber, J.1
Tchernitsa, O.I.2
Hinzmann, B.3
Schmitz, A.C.4
Grips, M.5
Hellriegel, M.6
Sers, C.7
Rosenthal, A.8
Schafer, R.9
-
32
-
-
0033793874
-
Ras proteins in the control of the cell cycle and cell differentiation
-
Crespo P., Leon J. Ras proteins in the control of the cell cycle and cell differentiation. Cell. Mol. Life Sci. 2000, 57:1613-1636.
-
(2000)
Cell. Mol. Life Sci.
, vol.57
, pp. 1613-1636
-
-
Crespo, P.1
Leon, J.2
-
33
-
-
72049092032
-
Ras promotes cell survival by antagonizing both JNK and Hid signals in the Drosophila eye
-
Wu Y., Zhuang Y., Han M., Xu T., Deng K. Ras promotes cell survival by antagonizing both JNK and Hid signals in the Drosophila eye. BMC Dev. Biol. 2009, 9:53.
-
(2009)
BMC Dev. Biol.
, vol.9
, pp. 53
-
-
Wu, Y.1
Zhuang, Y.2
Han, M.3
Xu, T.4
Deng, K.5
-
34
-
-
0028074316
-
Phosphatidylinositol-3-OH kinase as a direct target of Ras
-
Rodriguez-Viciana P., Warne P.H., Dhand R., Vanhaesebroeck B., Gout I., Fry M.J., Waterfield M.D., Downward J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994, 370:527-532.
-
(1994)
Nature
, vol.370
, pp. 527-532
-
-
Rodriguez-Viciana, P.1
Warne, P.H.2
Dhand, R.3
Vanhaesebroeck, B.4
Gout, I.5
Fry, M.J.6
Waterfield, M.D.7
Downward, J.8
-
35
-
-
79960055459
-
RAS interaction with PI3K: more than just another effector pathway
-
Castellano E., Downward J. RAS interaction with PI3K: more than just another effector pathway. Genes Cancer 2011, 2:261-274.
-
(2011)
Genes Cancer
, vol.2
, pp. 261-274
-
-
Castellano, E.1
Downward, J.2
-
36
-
-
0028341334
-
A single amino acid change in Raf-1 inhibits Ras binding and alters Raf-1 function
-
Fabian J.R., Vojtek A.B., Cooper J.A., Morrison D.K. A single amino acid change in Raf-1 inhibits Ras binding and alters Raf-1 function. Proc. Natl. Acad. Sci. USA 1994, 91:5982-5986.
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 5982-5986
-
-
Fabian, J.R.1
Vojtek, A.B.2
Cooper, J.A.3
Morrison, D.K.4
-
37
-
-
0029006126
-
Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation
-
Marais R., Light Y., Paterson H.F., Marshall C.J. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 1995, 14:3136-3145.
-
(1995)
EMBO J.
, vol.14
, pp. 3136-3145
-
-
Marais, R.1
Light, Y.2
Paterson, H.F.3
Marshall, C.J.4
-
38
-
-
0035787526
-
Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade
-
Avruch J., Khokhlatchev A., Kyriakis J.M., Luo Z., Tzivion G., Vavvas D., Zhang X.F. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog. Horm. Res. 2001, 56:127-155.
-
(2001)
Recent Prog. Horm. Res.
, vol.56
, pp. 127-155
-
-
Avruch, J.1
Khokhlatchev, A.2
Kyriakis, J.M.3
Luo, Z.4
Tzivion, G.5
Vavvas, D.6
Zhang, X.F.7
-
39
-
-
49649110128
-
Two new 5-hydroxy-2-pyrone derivatives isolated from a marine-derived fungus Aspergillus flavus
-
Lin A., Lu X., Fang Y., Zhu T., Gu Q., Zhu W. Two new 5-hydroxy-2-pyrone derivatives isolated from a marine-derived fungus Aspergillus flavus. J. Antibiot. (Tokyo) 2008, 61:245-249.
-
(2008)
J. Antibiot. (Tokyo)
, vol.61
, pp. 245-249
-
-
Lin, A.1
Lu, X.2
Fang, Y.3
Zhu, T.4
Gu, Q.5
Zhu, W.6
|